9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-ol

Catalog No. :
ACTGNI174
CAS No. :
93778-57-5
Molecular Formula :
C31H30N4O6
Molecular Weight :
554.60

IUPAC Name:9-((2R,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-ol

9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$51.00Login to see priceIn stockInquiry
25g98%$254.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-((2R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-ol
IUPAC Name9-((2R,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-ol
MDL No.MFCD00080301
Molecular FormulaC31H30N4O6
Molecular Weight554.60
SMILESO[C@@H](C[C@H](N1C=NC2=C1N=CN=C2O)O3)[C@H]3COC(C4=CC=C(OC)C=C4)(C5=CC=C(OC)C=C5)C6=CC=CC=C6
InChI KeyIYNGMVFRUKBGNM-OYUWMTPXSA-N
SynonymAS-49384 | AC-32199 | MFCD00057879 | CS-W011460 | AKOS037644237 | EINECS 298-195-2 | DMT-dI | 5'-O-(4,4'-Dimethoxytrityl)-2'-deoxyinosine | SCHEMBL18486353 | HY-W010744 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-deoxyinosine | HG1196 | 2'-Deoxy-5'-O-DMT
CAS No.93778-57-5
PubChem CID136192437

Synthetic Route by SureRoute

1. ACTGNI174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTGNI174 route product structure diagram
    ACTGNI17493778-57-5 In Stock
Inquiry

2. ACTGNI174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTGNI174 route product structure diagram
    ACTGNI17493778-57-5 In Stock
Inquiry

Comments (0)